The potential usefulness of combined ATR and RNR inhibition has been evaluated in a number of studies on diverse adult cancers (Liu et al. 2017; Fordham et al. 2018; Konstantinopoulos et al. 2020; Middleton et al. 2021). This evidence concerns the gene NR2E3 and cancer.